Fintel on MSN

HC Wainwright & Co. Maintains Vor Biopharma (VOR) Buy Recommendation

Fintel reports that on November 14, 2025, HC Wainwright & Co. maintained coverage of Vor Biopharma (NasdaqGS:VOR) with a Buy ...
Fintel on MSN

Vor Biopharma (VOR) Price Target Increased by 30.77% to 47.68

The average one-year price target for Vor Biopharma (NasdaqGS:VOR) has been revised to $47.68 / share. This is an increase of ...